Network News
The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The […]
read more
How immune cells become accomplices of tumors – Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum
Daniel Kirschenbaum has developed an experimental method for investigating immune responses in living organisms with high temporal resolution. The technique enabled him and his colleagues to reconstruct the temporal sequence of the immune response in malignant brain tumors for the first time. This opens up new perspectives for the development of targeted and temporally precise […]
read more
NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI
– Achieving Over 90% Accuracy, Wins First Place at GICHD-Sponsored Awards – Tokyo, Japan, October 29, 2025 — NEC Corporation (NEC; TSE: 6701) and the Cambodian Mine Action Center (CMAC, *1), the national institution responsible for landmine clearance activities in Cambodia, with assistance from JICA (*2), conducted a proof-of-concept using AI to predict landmine-contaminated areas. This […]
read more
Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Ladenburg, Germany, 6 November 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that HDP-101 (INN: pamlectabart tismanitin), the Company’s lead ATAC candidate for the treatment of relapsed or refractory multiple myeloma, shows further clinical activity in Cohort 8 at a dose level of 140 µg/kg. These […]
read more
ERC Synergy Grant for MPI Director Kai Johnsson
On the trail of contacts: European Research Council funds pioneering MitoContact project to investigate communication between mitochondria and other cell components Kai Johnsson, Director at the Max Planck Institute for Medical Research, has been awarded a Synergy Grant by the European Research Council (ERC). In the funded project MitoContact, he will work with two scientists from Switzerland to […]
read more
Two ERC Synergy Grants for Scientists at Universität Heidelberg
European Research Council awards prestigious funding for complex research projects Scientists at Heidelberg University are to receive two prestigious ERC Synergy Grants awarded by the European Research Council (ERC) for groundbreaking research projects that will be carried out jointly by several teams. Prof. Dr Dr Amir Abdollahi is coordinating a tri-national collaboration with colleagues in […]
read more
Brain Tumor Charity supports immunotherapy for childhood brain tumors with 1.5 million pounds sterling
Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the Hopp Children’s Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the Medical Faculty of Heidelberg University (MFHD) and […]
read more
SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows
Cambridge, UK, and Lausanne, Switzerland, 05 November 2025: SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing and transcriptomics, today announced a collaboration to provide an automated solution for single-cell transcriptomics. The collaboration integrates Alithea […]
read more
A human placenta model to protect pregnant women and their babies
EMBL researchers were awarded a BII foundation grant to support Model-MI – an in vitro model that mimics the maternal-fetal interface Pregnancy is a period of both excitement and concern for the healthy development of the foetus and the well-being of the expectant mother. During the ~40 weeks of gestation, many external factors constitute a danger for […]
read more
